ADTX - Aditxt, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Richmond,
United States
Type: Equity
ADTX price evolution
ADTX
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.2 | $1.96 | $0.38 | $0.71 |
| Short term investments | ||||
| Net receivables | $0.41 | $0.36 | $0.38 | $0.33 |
| Inventory | $0.75 | $0.86 | $1.02 | $0.76 |
| Total current assets | $6.91 | $3.43 | $2.15 | $1.94 |
| Long term investments | $22.28 | |||
| Property, plant & equipment | $4.1 | $4.46 | $4.81 | $5.15 |
| Goodwill & intangible assets | $0.01 | $0.03 | $0.05 | $0.08 |
| Total noncurrent assets | $37.67 | $4.8 | $5.15 | $5.69 |
| Total investments | $22.28 | |||
| Total assets | $44.58 | $8.23 | $7.29 | $7.63 |
| Current liabilities | ||||
| Accounts payable | $8.55 | $4.22 | $5.4 | $3.24 |
| Deferred revenue | ||||
| Short long term debt | $17.18 | $5.25 | $4.17 | $2.49 |
| Total current liabilities | $25.89 | $11.24 | $9.74 | $5.91 |
| Long term debt | $1.04 | $1.2 | $1.42 | $1.66 |
| Total noncurrent liabilities | $2.64 | $1.2 | $1.42 | $1.66 |
| Total debt | $18.22 | $6.45 | $5.59 | $4.14 |
| Total liabilities | $28.53 | $12.45 | $11.16 | $7.57 |
| Shareholders' equity | ||||
| Retained earnings | -$127.74 | -$116.62 | -$106.71 | -$101.03 |
| Other shareholder equity | ||||
| Total shareholder equity | $16.06 | -$4.22 | -$3.87 | $0.07 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.2 | $3.12 | $8.25 | $10.57 |
| Short term investments | $0.5 | |||
| Net receivables | $0.41 | $0.53 | $0.09 | |
| Inventory | $0.75 | $0.95 | $0.49 | |
| Total current assets | $6.91 | $4.74 | $9.42 | $11.03 |
| Long term investments | $22.28 | |||
| Property, plant & equipment | $4.1 | $5.48 | $6.36 | $2.05 |
| Goodwill & intangible assets | $0.01 | $0.11 | $0.21 | $0.32 |
| Total noncurrent assets | $37.67 | $5.99 | $7.25 | $2.06 |
| Total investments | $22.28 | $0.5 | ||
| Total assets | $44.58 | $10.74 | $16.66 | $13.1 |
| Current liabilities | ||||
| Accounts payable | $8.55 | $1.96 | $1.58 | $0.24 |
| Deferred revenue | ||||
| Short long term debt | $17.18 | $1.5 | $1.85 | $0.98 |
| Total current liabilities | $25.89 | $3.64 | $3.61 | $1.23 |
| Long term debt | $1.04 | $1.89 | $2.88 | $0.86 |
| Total noncurrent liabilities | $2.64 | $1.89 | $2.88 | $0.86 |
| Total debt | $18.22 | $3.38 | $4.72 | $1.84 |
| Total liabilities | $28.53 | $5.53 | $6.48 | $2.09 |
| Shareholders' equity | ||||
| Retained earnings | -$127.74 | -$95.04 | -$67.35 | -$20.88 |
| Other shareholder equity | -$0.2 | |||
| Total shareholder equity | $16.06 | $5.21 | $10.18 | $11.01 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.08 | $0.12 | $0.22 | $0.22 |
| Cost of revenue | $0.29 | $0.11 | $0.19 | $0.18 |
| Gross Profit | -$0.2 | $0.02 | $0.04 | $0.04 |
| Operating activities | ||||
| Research & development | $4.3 | $0.9 | $0.48 | $1.39 |
| Selling, general & administrative | $3.44 | $7.21 | $3.78 | $4.43 |
| Total operating expenses | $7.75 | $8.11 | $4.27 | $5.82 |
| Operating income | -$7.95 | -$8.1 | -$4.23 | -$5.78 |
| Income from continuing operations | ||||
| EBIT | -$9.16 | -$8.84 | -$4.4 | -$5.79 |
| Income tax expense | ||||
| Interest expense | $1.81 | $0.91 | $1.29 | $0.2 |
| Net income | ||||
| Net income | -$10.97 | -$9.75 | -$5.68 | -$5.98 |
| Income (for common shares) | -$11.12 | -$9.91 | -$5.68 | -$5.98 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.65 | $0.93 | $0.11 | |
| Cost of revenue | $0.76 | $0.77 | $0.08 | |
| Gross Profit | -$0.11 | $0.17 | $0.03 | |
| Operating activities | ||||
| Research & development | $7.07 | $7.27 | $5.04 | $0.94 |
| Selling, general & administrative | $18.88 | $17.84 | $22.42 | $7.93 |
| Total operating expenses | $25.95 | $25.65 | $27.46 | $8.87 |
| Operating income | -$26.06 | -$25.48 | -$27.43 | -$8.87 |
| Income from continuing operations | ||||
| EBIT | -$28.19 | -$26.86 | -$46.28 | -$9.14 |
| Income tax expense | ||||
| Interest expense | $4.2 | $0.75 | $0.09 | $0.01 |
| Net income | ||||
| Net income | -$32.38 | -$27.61 | -$46.37 | -$9.15 |
| Income (for common shares) | -$32.7 | -$27.61 | -$46.37 | -$9.15 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$10.97 | -$9.75 | -$5.68 | -$5.98 |
| Operating activities | ||||
| Depreciation | $0.13 | $0.14 | $0.14 | $0.14 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.75 | $0.15 | $0.16 | $0.34 |
| Total cash flows from operations | -$3.31 | -$8.03 | -$3.28 | -$3.95 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0 | -$0.01 | |
| Investments | ||||
| Total cash flows from investing | -$0.01 | -$0 | -$0.01 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.51 | $10.04 | $0.51 | |
| Net borrowings | $1.76 | $0.63 | $1.49 | $0.98 |
| Total cash flows from financing | $1.76 | $9.6 | $3.08 | $1.49 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.55 | $1.56 | -$0.21 | -$2.47 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$32.38 | -$27.61 | -$46.37 | -$9.15 |
| Operating activities | ||||
| Depreciation | $0.54 | $0.54 | $0.48 | $0.02 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.4 | $3.13 | $4.64 | $3.19 |
| Total cash flows from operations | -$18.58 | -$22.39 | -$22.28 | -$7.22 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.37 | -$1.02 | -$0.17 |
| Investments | -$15 | |||
| Total cash flows from investing | -$0.01 | -$0.24 | -$16.31 | -$0.17 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $11.06 | $17.23 | $33.6 | $18.5 |
| Net borrowings | $4.86 | -$0.81 | $2.36 | -$0.4 |
| Total cash flows from financing | $15.92 | $17.53 | $35.95 | $17.89 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.67 | -$5.1 | -$2.63 | $10.5 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $645.18K |
|---|---|
| EBITDA | -$27.64M |
| EBIT | -$28.19M |
| Net Income | -$32.38M |
| Revenue Q/Q | -56.20% |
| Revenue Y/Y | -30.90% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -191.23% |
| ROE | -1.61K% |
| Debt/Equity | 1.78 |
|---|---|
| Net debt/EBITDA | -1.02 |
| Current ratio | 0.27 |
| Quick ratio | 0.24 |